Human helminth therapy to treat inflammatory disorders- where do we stand?
Author:
Open Access
- 26 March 2015
- journal article
- review article
- Published by Springer Nature in BMC Immunology
- Vol. 16 (1) , 1-5
Abstract
Parasitic helminths have evolved together with the mammalian immune system over many millennia and as such they have become remarkably efficient modulators in order to promote their own survival. Their ability to alter and/or suppress immune responses could be beneficial to the host by helping control excessive inflammatory responses and animal models and pre-clinical trials have all suggested a beneficial effect of helminth infections on inflammatory bowel conditions, MS, asthma and atopy. Thus, helminth therapy has been suggested as a possible treatment method for autoimmune and other inflammatory disorders in humans.Keywords
This publication has 43 references indexed in Scilit:
- Helminth–host immunological interactions: prevention and control of immune‐mediated diseasesAnnals of the New York Academy of Sciences, 2012
- Suppression of Inflammatory Immune Responses in Celiac Disease by Experimental Hookworm InfectionPLOS ONE, 2011
- Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive PathogensPLOS Pathogens, 2011
- Strongyloides ratti Infection Induces Expansion of Foxp3+ Regulatory T Cells That Interfere with Immune Response and Parasite Clearance in BALB/c MiceThe Journal of Immunology, 2011
- The impact of parasite infections on the course of multiple sclerosisJournal of Neuroimmunology, 2011
- Effect of Hookworm Infection on Wheat Challenge in Celiac Disease – A Randomised Double-Blinded Placebo Controlled TrialPLOS ONE, 2011
- Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 studyMultiple Sclerosis Journal, 2011
- Farm living: effects on childhood asthma and allergyNature Reviews Immunology, 2010
- Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trialJournal of Allergy and Clinical Immunology, 2010
- Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double‐blind, placebo‐controlled trial in VietnamClinical & Experimental Allergy, 2009